Jason B White - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jason B White

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Breast Cancer Research : BCR|May 7, 2026

The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.

Cancer Research Communications|October 2, 2024

Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II StudyClinton Yam, Miral Patel, Holly A Hill, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Breast Cancer Research : BCR|May 7, 2026

The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.

Cancer Research Communications|October 2, 2024

Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II StudyClinton Yam, Miral Patel, Holly A Hill, et al.

Pageof 6